ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0. A total of 9 filers reported holding ACORDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,244,146 | -15.0% | 52,324,000 | 0.0% | 0.45% | -35.7% |
| Q2 2023 | $33,209,520 | -0.8% | 52,324,000 | 0.0% | 0.70% | +22.1% |
| Q1 2023 | $33,492,122 | +99558.2% | 52,324,000 | 0.0% | 0.57% | +14125.0% |
| Q4 2022 | $33,607 | -99.9% | 52,324,000 | 0.0% | 0.00% | -99.4% |
| Q3 2022 | $38,193,000 | -0.0% | 52,324,000 | 0.0% | 0.70% | +5.7% |
| Q2 2022 | $38,202,000 | +1.5% | 52,324,000 | +4.0% | 0.66% | +37.1% |
| Q1 2022 | $37,649,000 | -3.2% | 50,324,000 | +4.1% | 0.48% | -15.7% |
| Q4 2021 | $38,901,000 | 0.0% | 48,324,000 | 0.0% | 0.57% | +3.1% |
| Q3 2021 | $38,901,000 | +16.3% | 48,324,000 | +5.5% | 0.56% | +113.8% |
| Q2 2021 | $33,452,000 | +1.5% | 45,824,000 | 0.0% | 0.26% | -20.7% |
| Q1 2021 | $32,970,000 | – | 45,824,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 45,283,000 | $34,302,000 | 0.80% |
| CANYON CAPITAL ADVISORS LLC | 25,875,000 | $19,875,000 | 0.74% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 50,324,000 | $37,649,000 | 0.48% |
| Soros Fund Management | 28,001,000 | $21,167,000 | 0.32% |
| Saltoro Capital, LP | 1,500,000 | $1,137,000 | 0.27% |
| D. E. Shaw & Co., Inc. | 14,000,000 | $10,662,000 | 0.01% |
| Jefferies Group LLC | 2,000,000 | $1,539,998 | 0.01% |
| WELLS FARGO & COMPANY/MN | 5,018,000 | $3,801,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |